Latest News

£12 million investment for Oxford University Innovation spin-out Nightstar

30th January 2014

All News | Financial News | Spinouts & Startups | Technology News

Wellcome Trust's VC arm backs an Isis spinout developing a gene therapy for inherited blindness.

Isis spin-out Oxcept focuses on secure mobile-to-mobile payments

30th January 2014

All News | Spinouts & Startups | Startup Incubator

'Imagine a piece of software that would allow the soldiers, aid workers and government officials thrown together after a disaster to quickly and securely communicate with each other whatever device they hold in their hands....

Isis spin-out Oxford Immunotec goes from strength to strength

24th January 2014

All News | Spinouts & Startups

Oxford Immunotec announces preliminary fourth quarter revenues

Oxford spinout to use ultrasound to treat cancer and back pain

22nd January 2014

All News | Spinouts & Startups | Technology News

Oxford University Innovation announced that OxSonics has raised £2.7 million to develop therapeutic technology which uses ultrasound devices in combination with ultrasound-sensitive nanoparticles.

Immunocore and Medimmune team up to develop cancer therapies

21st January 2014

All News | Spinouts & Startups

Immunocore has entered into an oncology research collaboration and licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca.

Isis Start-up Colwiz Launches HTML5 Interactive PDF Reader

4th December 2013

All News | Spinouts & Startups

Colwiz has announced the launch of the first HTML5 interactive PDF reader.

Oxford Researchers Working on New Drugs to Treat Duchenne Muscular Dystrophy

25th November 2013

All News | Spinouts & Startups

Reviving a gene which is “turned down” after birth is potentially the key to treating Duchenne Muscular Dystrophy, an untreatable muscle-wasting condition which affects one in every 3,500 boys.

Immunotec Oxford Raises $64m in Nasdaq IPO

25th November 2013

All News | Financial News | Spinouts & Startups | Technology News

Oxford Immunotec – a 2002 Isis spin-out – has raised US$64 million in an IPO on America’s Nasdaq stock exchange. The Abingdon-based company sells diagnostic tests for latent tuberculosis infection, T-SPOT®.TB.

Immuncore Hits Milestone in GSK Collaboration

12th November 2013

All News | Spinouts & Startups | Technology News

Immunocore Limited, the Oxford based biotechnology company developing novel biological drugs to treat cancer and viral disease has announced the achievement of its first milestone in its research and licensing agreement with GlaxoSmithKline.

Isis Spin-outs Win OBN Awards

11th October 2013

All News | Spinouts & Startups | Technology News

Oxford University Innovation spin-outs, Oxford Gene Technology and OrganOx have won an award each at the OBN Annual Awards Dinner held on 1st October. The OBN is a membership organisation supporting and bringing together the UK’s emerging life science R&D companies, their corporate partners and investors.

News

Ready to get in touch?